183 related articles for article (PubMed ID: 27611985)
1. Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: A randomized, double blind and controlled clinical trial.
Li ZM; Xiao YL; Zhu JX; Geng FY; Guo CJ; Chong ZL; Wang LX
Clin Neurol Neurosurg; 2016 Nov; 150():80-83. PubMed ID: 27611985
[TBL] [Abstract][Full Text] [Related]
2. [Effects of erythropoietin on serum NSE and S-100B levels in neonates with hypoxic-ischemic encephalopathy].
Pei XM; Gao R; Zhang GY; Lin L; Wan SM; Qiu SQ
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):705-8. PubMed ID: 25008877
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of Severe Traumatic Brain Injury Outcomes in Children.
Meshcheryakov SV; Semenova ZB; Lukianov VI; Sorokina EG; Karaseva OV
Acta Neurochir Suppl; 2018; 126():11-16. PubMed ID: 29492523
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
5. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
[TBL] [Abstract][Full Text] [Related]
6. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.
Pleines UE; Morganti-Kossmann MC; Rancan M; Joller H; Trentz O; Kossmann T
J Neurotrauma; 2001 May; 18(5):491-8. PubMed ID: 11393252
[TBL] [Abstract][Full Text] [Related]
7. S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury.
Rodríguez-Rodríguez A; Egea-Guerrero JJ; Gordillo-Escobar E; Enamorado-Enamorado J; Hernández-García C; Ruiz de Azúa-López Z; Vilches-Arenas Á; Guerrero JM; Murillo-Cabezas F
Neurol Res; 2016 Feb; 38(2):130-7. PubMed ID: 27078699
[TBL] [Abstract][Full Text] [Related]
8. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
Nguyen DN; Spapen H; Su F; Schiettecatte J; Shi L; Hachimi-Idrissi S; Huyghens L
Crit Care Med; 2006 Jul; 34(7):1967-74. PubMed ID: 16607230
[TBL] [Abstract][Full Text] [Related]
10. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of erythropoietin for traumatic brain injury.
Liu M; Wang AJ; Chen Y; Zhao G; Jiang Z; Wang X; Shi D; Zhang T; Sun B; He H; Williams Z; Hu K
BMC Neurol; 2020 Nov; 20(1):399. PubMed ID: 33138778
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial.
Hellewell SC; Mondello S; Conquest A; Shaw G; Madorsky I; Deng JV; Little L; Kobeissy F; Bye N; Bellomo R; Cooper DJ; Vallance S; Board J; Morganti-Kossmann MC
Crit Care Med; 2018 Apr; 46(4):554-561. PubMed ID: 29278529
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Changes in Disability Rating Scale Scores: A Secondary Analysis Among Patients With Severe TBI Enrolled in the Epo Clinical Trial.
Benoit JS; Hannay HJ; Yamal JM; Francis DJ; Aisiku I; Robertson C
J Int Neuropsychol Soc; 2019 Mar; 25(3):293-301. PubMed ID: 30864534
[TBL] [Abstract][Full Text] [Related]
14. A pilot trial of l-carnitine in patients with traumatic brain injury: Effects on biomarkers of injury.
Mahmoodpoor A; Shokouhi G; Hamishehkar H; Soleimanpour H; Sanaie S; Porhomayon J; Rasouli F; Nader ND
J Crit Care; 2018 Jun; 45():128-132. PubMed ID: 29454227
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.
Skrifvars MB; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
J Trauma Acute Care Surg; 2017 Sep; 83(3):449-456. PubMed ID: 28590358
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.
Liu WC; Wen L; Xie T; Wang H; Gong JB; Yang XF
J Neurosurg; 2017 Jul; 127(1):8-15. PubMed ID: 27367243
[TBL] [Abstract][Full Text] [Related]
17. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.
Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB
J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968
[TBL] [Abstract][Full Text] [Related]
18. Effect of Memantine on Serum Levels of Neuron-Specific Enolase and on the Glasgow Coma Scale in Patients With Moderate Traumatic Brain Injury.
Mokhtari M; Nayeb-Aghaei H; Kouchek M; Miri MM; Goharani R; Amoozandeh A; Akhavan Salamat S; Sistanizad M
J Clin Pharmacol; 2018 Jan; 58(1):42-47. PubMed ID: 28724200
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
20. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
